Page last updated: 2024-08-23

mefloquine and Liver Neoplasms

mefloquine has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gong, LL; Li, YH; Lin, RX; Wu, JC; Yang, SL; Zhang, GF	1

Other Studies

1 other study(ies) available for mefloquine and Liver Neoplasms

Article	Year
Mefloquine targets β-catenin pathway and thus can play a role in the treatment of liver cancer. Microbial pathogenesis, 2018, Volume: 118 Topics: AC133 Antigen; Animals; beta Catenin; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cyclin D1; Disease Models, Animal; Drug Combinations; Hep G2 Cells; Humans; Lithium Chloride; Liver Neoplasms; Male; Mefloquine; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Transplantation, Heterologous	2018

Article

Year

Mefloquine targets β-catenin pathway and thus can play a role in the treatment of liver cancer.

Microbial pathogenesis, 2018, Volume: 118

Topics: AC133 Antigen; Animals; beta Catenin; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Cyclin D1; Disease Models, Animal; Drug Combinations; Hep G2 Cells; Humans; Lithium Chloride; Liver Neoplasms; Male; Mefloquine; Mice; Mice, Inbred BALB C; Neoplastic Stem Cells; Transplantation, Heterologous

2018